Pfizer COVID-19 Vaccine Approved in Canada, Likely to Enter Use Next Week
By Kyodo News 10 December 2020
NEW YORK—Canada on Wednesday approved the emergency use of a coronavirus vaccine developed by pharmaceutical giant Pfizer Inc. and German partner BioNTech SE, becoming the third country to do so following Britain and Bahrain.
Vaccinations in the country are likely to start next week, initially targeting elderly people and medical staff in nursing care facilities, with a supply of around 250,000 doses expected to be provided by the end of the year, according to local media reports.
You may also like these stories: